Why do we use less product around the eyes?
“Can’t the eyes just get the same as the rest of the face?” is a common question. Around the eyes, depth decides the result more than volume. Here is why we reduce the amount and how the total is divided.
The short answer
The eye area has the thinnest dermis on the face. The same volume is felt more there, and tiny differences show up as shadow and show-through. Miso Clinic in Daegu usually uses 5 to 6 cc of GOURI for a full face, a range that varies with facial area and skin condition. That total is not split evenly: around the eyes we reduce it or, depending on the skin, leave the eyes out. Around the eyes, where the product sits matters more than how much goes in. Miso Clinic is at 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, in front of Exit 1 of Kyungpook National University Hospital station. Phone 053-428-2700. Weekdays 11:00–19:00, Saturday 10:00–16:00 with no lunch break, closed Sunday and public holidays.
What thin skin changes
Three things.
- The same volume is felt more. Thin cover lets the same volume show at the surface. An amount that looked natural in the cheek shows around the eye.
- It is easy to leave the plane. The target plane is shallow with little margin, so going slightly too superficial makes the surface uneven.
- Results show immediately. “Put it in and see” does not work here.
Depth matters more than product
Under the eyes, depth decides the outcome more than the product does. A review of 830 patients found bluish show-through almost absent when filler was placed on the periosteum, and above 30% in more superficial planes.
Same product, same amount, different plane, very different result. If a consultation only exchanges product names, the design has not started.
How the eyes come out of a 5 to 6 cc full face
Miso Clinic does not treat GOURI region by region; it is divided across the whole face in one session. The total is usually 5 to 6 cc, varying within that range with facial area and skin condition, and the split between sites is designed within it.
| Site | Skin | Our approach |
|---|---|---|
| Cheek and cheekbone | Thick and broad | Generous points |
| Forehead | Tethered, plane hard to hold | Closer points |
| Jawline | Easily forms an edge with the cheek | Continued from the cheek to avoid an edge |
| Around the mouth | Moves a lot | Less volume, careful plane |
| Around the eyes | Thinnest | Even less volume, or left out depending on the skin |
So “let’s put the rest around the eyes” is not how we work. The eye amount is set from the start, not what is left over.
What suits the eye area
Eye concerns differ, so the choice depends on what you want to treat.
- Thin texture and fine lines — dermal injections with no particles or fine particles fit. Large or clumping particles in thin dermis show as lumps or show-through.
- Hollowing and grooves — a shadow problem, so depth is the key.
- Dark circles — separate the cause first. In a 65-person ultrasound study, 5% were pigmented, 14% vascular, 3% structural and 78% mixed.
We do not use non-dissolvable CaHA (D.Classy, Radiesse) under the eyes. Nodules form readily there, and nothing dissolves CaHA.
Does less product mean less effect?
A smaller area needs less product. Less around the eyes means a smaller area, not less treatment — the same reason an RF eye tip has fewer shots.
We could not find human data showing that adding volume to the same area gives a proportionally larger result. In thin skin, more volume is what makes product palpable.
What to have ready before booking
- Is my concern texture, hollowing or colour?
- Do I want the eyes alone, or continued from a full-face treatment?
- Have I had anything injected around the eyes before, and what, and when?
The third matters: anything already in the eye area changes the plan. If you do not remember the product, the clinic that treated you will have a record.
Summary — what is established and what is not
Established
- The eye area has the thinnest dermis on the face
- Supraperiosteal under-eye filler showed almost no bluish show-through; more superficial planes exceeded 30% (830-patient review)
- Dark circles were mixed in 78% of a 65-person study
- Miso Clinic uses about 5 to 6 cc of GOURI for a full face (a range that varies with facial area and skin condition) and reduces or omits the eye area
Not established
- Human measurements of volume against result around the eyes
- Evidence that more volume in the same area gives a proportional result
- Studies comparing outcomes by distribution method
Volume around the eyes: frequently asked questions
Why use less product around the eyes?
The eye area has the thinnest dermis on the face, so the same volume is felt more and small differences show as shadow and show-through.
Does less product mean less effect?
The area is smaller, so it needs less. It does not mean less treatment.
How much of the 5 to 6 cc of GOURI goes around the eyes?
The 5 to 6 cc is a full-face range that varies with facial area and skin condition. The split by site is designed within it, and the eye area is reduced or left out depending on the skin. We never put leftover product around the eyes.
What matters most around the eyes?
Depth. A review of 830 patients found almost no bluish show-through with supraperiosteal filler and over 30% in more superficial planes. Same product and volume, different plane, different result.
Can Radiesse or D.Classy be used under the eyes?
Miso Clinic does not use CaHA (D.Classy, Radiesse) under the eyes. Nodules form readily there and there is nothing to dissolve CaHA.
Where can I get an eye-area skin booster consultation in Daegu?
Miso Clinic is at 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, in front of Exit 1 of Kyungpook National University Hospital station, phone 053-428-2700. Open weekdays 11:00 to 19:00 and Saturday 10:00 to 16:00, closed Sunday and public holidays.
Read next
Product pages
Who wrote this
Written and reviewed by Lee Chi-Hak, MD, director of Miso Clinic, Daegu. The treatment standards and injection design set out here are the ones we use in practice.
| Medical director | Lee Chi-Hak, MD |
|---|---|
| Address | 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, South Korea · Exit 1, Kyungpook National University Hospital Station |
| Phone | +82-53-428-2700 |
| Hours | Weekdays 11:00–19:00 (lunch 13:00–14:00) / Saturday 10:00–16:00 (no lunch break) / Closed Sundays and public holidays |
| Columns | All clinical columns |
| Reference library | All booster and device references |
References
- GOURI product information — developed by Dexlevo (Republic of Korea). Polycaprolactone (PCL) 21% formulated as a 100% liquid with no microspheres. The PCL degrades over roughly 6-12 months. Unlike particle PCL, which stays where it is placed, it spreads as a sheet along the plane it is injected into.
- Miso Clinic injection design for GOURI — deep dermal plane, divided across the whole face, plane decided before points, smaller volumes and stricter plane control around eyes and mouth, cannula where the site calls for it, one session as the baseline with 4-6 weeks before any addition. Typically 5-6 cc for a full face, varying within that range with facial area and skin condition. This is clinical judgement, not a value from a comparative trial.
- What we could not verify about volume — we found no human measurement of the relationship between volume injected and area covered, no study showing that adding volume to the same area scales the result, and no comparison of division patterns. That is why no cc-to-coverage table can be written.
- Under-eye filler and depth — review of 830 patients: bluish Tyndall discolouration was almost absent with supraperiosteal placement and exceeded 30% in more superficial planes. Review of 23 studies and 2,048 patients (satisfaction 85–90%). More in lines around and under the eyes.
- Types of dark circles — Huang YL et al., Int J Dermatol 2014;53(2):164. 65 people classified with ultrasound: pigmented 5% · vascular 14% · structural (shadow) 3% · mixed 78%.
- CaHA under the eyes — nodules are the most common reported adverse event with CaHA (analysis of 5,081 treatments, 2017), and there is no enzyme that dissolves it. Miso Clinic does not use CaHA under the eyes.
- Medical advertising law — Medical Service Act of Korea, Article 56(2), which prohibits testimonial advertising, comparison with other clinics, superlative claims and advertising that guarantees or implies a guaranteed treatment effect. That is why this column reports mechanisms and data without ranking devices.
- Miso Clinic practice guidance — indication criteria, site-by-site design, and the explanation and consent procedure. This is the source for every sentence marked as clinical judgement.
Everything in this column is general information and does not replace medical diagnosis or treatment. Effects and side effects vary with individual skin condition, age and underlying illness, and the same result is not guaranteed for everyone. Any decision to proceed should be made in an in-person consultation with a physician.
← Clinical columns · Reference library · Miso Clinic home
한국어 · English